1. Tissue dosimetry in risk assessment, or what’s the problem here anyway?;Andersen,1987
2. ATSDR. 2004. Guidance manual for the assessment of joint toxic action of chemical mixtures, Agency for Toxic Substances and Disease Registry, Public Health Service, U.S. Department of Health and Human Services.
3. Anthraflavic is a potent and specific inhibitor of cytochrome P448 activity;Ayrton;Biochim. Biophys. Acta.,1987
4. Determination of P4501A2 activity in human liver microsomes using [3-14C-methyl] caffeine;Bloomer;Xenobiotica,1995
5. Elucidation of phase I and phase II metabolic pathways of rhein: species differences and their potential relevance;Dahms;Drug Metab. Dispos.,1997